Company / Total Assets
Haemonetics Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$2.5B
FY2025
5-year range
$1.9B / $2.5B
FY2021-FY2025
Trend
+11.6%
vs FY2024
Sector context
#85 of 161
Health Care
What the data says
At $2.5B, Haemonetics's total assets ranks #85 of 161 in the Health Care sector. Total Assets has increased for 5 consecutive years, from $1.3B in FY2020 to $2.5B in FY2025.
Based on SEC 10-K filings.
$2.5B in FY2025 with a 5-year CAGR of +14.1%.
Improved from $1.9B to $2.5B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +9.6%
- 5-Year CAGR
- +14.1%
- 10-Year CAGR
- -
Sector benchmark
#85 of 161 in Health CareTop 53% of 161This company $2.5B Sector average $14.8B
▼
-83.4% below sector average
Key checks
Key Insights
- Haemonetics's total assets has grown for 5 consecutive years.
- 5-year CAGR of +14.1%, indicating consistent growth.
- In FY2025, total assets increased 11.6% year-over-year.
- Ranks #85 out of 161 companies in the Health Care sector.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $2.5B | +11.6% |
| FY2024 | $2.2B | +13.5% |
| FY2023 | $1.9B | +4.0% |
| FY2022 | $1.9B | +2.2% |
| FY2021 | $1.8B | +43.6% |
| FY2020 | $1.3B | -0.6% |
| FY2019 | $1.3B | +3.0% |
| FY2018 | $1.2B | -0.1% |
| FY2017 | $1.2B | -6.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026